Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Real-World Analysis of Outcomes with Combination MIGS and Cataract Surgery
Author Affiliations & Notes
  • Brittany Bowman
    Georgia Eye Partners, Atlanta, Georgia, United States
  • Gagan Sawhney
    Georgia Eye Partners, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Brittany Bowman None; Gagan Sawhney None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3499. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brittany Bowman, Gagan Sawhney; Real-World Analysis of Outcomes with Combination MIGS and Cataract Surgery. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3499.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Combination microinvasive glaucoma surgery (MIGS) and cataract surgery have reported to be effective in reducing intraocular pressure (IOP) compared to cataract surgery alone. However, long-term data from clinical practice is lacking. The purpose of this study is to determine the long term intraocular pressure (IOP) and medication reduction after combination cataract and Hydrus Microstent surgery.

Methods : This was a retrospective, single site, single surgeon study of patient outcomes with combination cataract and Hydrus Microstent surgery up to 3 years postoperatively. An Institutional Review Board (IRB) reviewed and approved this study and granted a waiver of informed consent. Eligible charts were from adults that had a diagnosis of mild to moderate primary open angle glaucoma or ocular hypertension and underwent combined cataract surgery with Hydrus Microstent with a minimum of 6 months of follow-up data available. Outcome measures included mean number of ocular hypotensive medication prescribed, intraocular pressure (IOP), and corrected distance visual acuity (CDVA).

Results : A total of 217 eyes were identified that met the inclusion and exclusion criteria above. Mean medications improved from 2.68 ± 1.16 at baseline to 1.56 ± 1.30, 1.72 ± 1.44, and 2.02 ± 1.28 at 12, 24, and 36 months postoperatively, respectively. Intraocular pressure improved from 16.05 ± 4.64 mmHg at baseline to 12.62 ± 2.93 mmHg, 12.97 ± 3.94 mmHg, and 12.86 ± 2.48 mmHg at 12, 24, and 36 months postoperatively respectively. Mean postoperative CDVA was 0.12 ± 0.27 logMAR, 0.12 ± 0.27 logMAR, 0.17 ± 0.37 logMAR at 12, 24, and 36 months, respectively, compared to 0.22 ± 0.35 logMAR at baseline.

Conclusions : The results of this study suggest that after combination cataract and Hydrus Microstent surgery the number of glaucoma medications is reduced and IOP is improved and these outcomes are sustained for 3 years postoperatively.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×